Axcelead Drug Discovery Partners (DDP)
Analytical & Bioanalytical Services
Contract Research Organization
Company Overview
About
Axcelead Drug Discovery Partners (DDP) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Respiratory
Allergy
Quick Facts
HQ:Japan
Founded:2003
Employees:2,443
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Manufacturing
- Formulation Development
Technology Platforms
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Sterile Injectable
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
Europe
Manufacturing Facilities
1 site worldwide
Axcelead Drug Discovery Partners (DDP) - Japan Facility
Japan
Site Capabilities
Gene Therapy
Cell Therapy
mRNA
Regulatory Approvals
Drug Approval TPWGUO
PMDA · #APR-VMZMUC7T · 2022-10-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-F5K4SVZF
Issued: 2020-01-28
Expires: 2025-02-21
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-J7KPACQP
Issued: 2020-07-05
Expires: 2025-04-24
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-ON851SLR
Issued: 2020-07-21
Expires: 2025-10-07
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-0OA0ZDFH
Issued: 2020-06-03
Expires: 2025-03-01
Customer Reviews
No reviews available yet.
Company Documents
No documents available.
Loading CDMO intelligence...